13D/13G Filings - Achilles Therapeutics plc (ACHL)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-13
5:02 pm
Unchanged
2024-12-31 13G Achilles Therapeutics plc
ACHL
BML Investment Partners, L.P. 4,100,002
9.970%
0
(Unchanged)
Filing
History
2024-11-14
4:23 pm
Sale
2024-09-30 13G Achilles Therapeutics plc
ACHL
Baker Bros. Advisors LP 0
0.000%
-3,311,567decrease
(Position Closed)
Filing
History
2024-09-25
7:14 pm
Purchase
2024-09-19 13G Achilles Therapeutics plc
ACHL
BML Investment Partners, L.P. 4,100,002
9.970%
4,100,002increase
(New Position)
Filing
History
2024-03-29
4:30 pm
Sale
2024-03-29 13G Achilles Therapeutics plc
ACHL
Artal Participations S.a r.l 755,375
1.900%
-1,500,000decrease
(-66.51%)
Filing
History
2024-02-14
4:21 pm
Sale
2023-12-31 13G Achilles Therapeutics plc
ACHL
Baker Bros. Advisors LP 3,311,567
8.100%
-896,166decrease
(-21.30%)
Filing
History
2024-02-13
6:40 pm
Unchanged
2023-12-31 13G Achilles Therapeutics plc
ACHL
Syncona Portfolio Ltd 11,086,909
27.200%
0
(Unchanged)
Filing
History
2023-02-14
4:29 pm
Sale
2022-12-31 13G Achilles Therapeutics plc
ACHL
Redmile Group LLC 1,608,089
3.900%
-480,000decrease
(-22.99%)
Filing
History
2023-02-14
4:00 pm
Purchase
2022-12-31 13G Achilles Therapeutics plc
ACHL
Baker Bros. Advisors LP 4,207,733
9.900%
168,253increase
(+4.17%)
Filing
History
2023-02-14
4:00 pm
Sale
2022-12-31 13G Achilles Therapeutics plc
ACHL
Point72 Asset Management, L.P. 1,413,809
3.600%
-667,241decrease
(-32.06%)
Filing
History
2023-02-10
7:15 pm
Unchanged
2022-12-31 13G Achilles Therapeutics plc
ACHL
Artal Participations S.a r.l 2,255,375
5.500%
0
(Unchanged)
Filing
History
2022-12-30
4:57 pm
Sale
2022-12-28 13D Achilles Therapeutics plc
ACHL
RA Capital Management, L.P. 1,607,834
13.000%
-1,369,109decrease
(-45.99%)
Filing
History
2022-12-23
5:15 pm
Sale
2022-12-21 13D Achilles Therapeutics plc
ACHL
RA Capital Management, L.P. 2,976,943
13.000%
-1,130,565decrease
(-27.52%)
Filing
History
2022-12-15
5:01 pm
Sale
2022-12-13 13D Achilles Therapeutics plc
ACHL
RA Capital Management, L.P. 4,107,508
13.000%
-907,179decrease
(-18.09%)
Filing
History
2022-07-25
5:20 pm
Purchase
2022-07-15 13G Achilles Therapeutics plc
ACHL
Point72 Asset Management, L.P. 2,081,050
5.300%
2,081,050increase
(New Position)
Filing
History
2022-02-14
5:07 pm
Purchase
2021-12-31 13G Achilles Therapeutics plc
ACHL
Redmile Group LLC 2,088,089
5.100%
2,088,089increase
(New Position)
Filing
History
2022-02-14
4:12 pm
Purchase
2021-12-31 13G Achilles Therapeutics plc
ACHL
Baker Bros. Advisors LP 4,039,480
9.990%
4,039,480increase
(New Position)
Filing
History
2022-02-11
12:22 pm
Purchase
2021-12-31 13G Achilles Therapeutics plc
ACHL
Syncona Portfolio Ltd 11,086,909
27.300%
11,086,909increase
(New Position)
Filing
History
2022-02-11
09:20 am
Purchase
2021-12-31 13G Achilles Therapeutics plc
ACHL
Forbion Capital Fund IV Cooperatief U.A. 2,390,050
5.890%
2,390,050increase
(New Position)
Filing
History
2021-04-16
4:34 pm
Purchase
2021-04-06 13D Achilles Therapeutics plc
ACHL
RA Capital Management, L.P. 5,014,687
12.340%
5,014,687increase
(New Position)
Filing
History
2021-04-15
5:02 pm
Purchase
2021-04-05 13G Achilles Therapeutics plc
ACHL
Artal Participations S.a r.l 2,255,375
5.600%
2,255,375increase
(New Position)
Filing
History